Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3)
Abstract Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-025-23554-2. Article type: Research Article Keywords: HLA-G, CBD, High-CBD extract (CBD-HCE), JEG-3, Immunomodulation, Cancer, Drug discovery, Immunology, Oncology Authors: Kevin I. Martínez, María B. Palma, Fernando J. Sepúlveda, Damián E. Moavro, Edgardo D. Carosella, Marcela N. García, Fernando L. Riccillo Affiliations: https://ror.org/01tjs6929grid.9499.d0000 0001 2097 3940Department of Citology, Histology and Embriology, School of Medical Sciences, National University of La Plata, La Plata, Argentina; https://ror.org/03cqe8w59grid.423606.50000 0001 1945 2152National Scientific and Technical
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
